April 2022 - Page 4 of 4 - PsychedelicNewsWire (PNW)

TuesdayApr 05, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics into therapeutics. Cybin’s (NEO: CYBN) (NYSE American: CYBN) efforts to transform the mental-health treatment landscape have reached a key milestone: the company is actively recruiting participants for its upcoming feasibility study using Kernel Flow, Kernel’s quantitative neuroimaging technology (https://ibn.fm/9aSxc). “The feasibility study using Kernel Flow offers an opportunity for researchers and our study participants to quantifiably gather information on a psychedelic experience,” said Cybin…

TuesdayApr 05, 2022 9:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leveraging Growth Across Multiple Markets Including Mental Health, Healthcare IT

Mydecine was founded in 2020 as a response to the lack of innovation addressing mental health treatment and the therapeutic possibilities represented by psychedelic compounds and other novel molecules The world is experiencing a shortage of mental health resources, while faced with an increase in mental health issues on the heels of the pandemic Mydecine is leveraging the psychedelic drugs market, the PTSD market, and healthcare IT markets – with potential growth across all avenues In the first year of the COVID-19 pandemic, the prevalence of anxiety and depression worldwide increased by 25%, according to a World Health Organization (“WHO”)…

MondayApr 04, 2022 1:46 pm

Activists in Michigan Start Signature Collection Efforts for Psychedelic Legalization Ballot Measure

Earlier this week, activists in the state of Michigan began a signature drive to collect signatures to place an initiative to legalize the sharing, possession and cultivation of psychedelics on the coming statewide ballot. Students for Sensible Drug Policy, a youth-led organization, and the Decriminalize Nature chapter in Michigan are collaborating in this effort. The measure would establish a system for the spiritual and therapeutic use of psychedelic substances. The legislation also permits counseling, spiritual, harm reduction, therapeutic, guidance, supervision and associated supportive services. The initiative also authorizes entities that have acquired a certificate of need from the state’s Department…

MondayApr 04, 2022 9:15 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO to Present at Three Upcoming Investor Conferences Spotlighting the Company’s Strategic Outlook for the Remainder of 2022

Delic Holdings Co-founder and CEO, Matt Stang, will take part in three upcoming conferences – the Scottdale Capital Event, the Planet MicroCap Showcase, and the H.C. Wainwright Annual Global Life Sciences Conference In presentations and one-on-one meetings, Stang will discuss Delic’s new revenue lines and strategic outlook for the remainder of the year During a recent interview on The Jesse Tee Show, Stang noted the company intends to scale its ketamine clinics as well as build infrastructure to accommodate expanded psychedelic healing The company hopes to utilize its expanded infrastructure to help destigmatize mental health conditions Delic Holdings (CSE: DELC)…

FridayApr 01, 2022 3:03 pm

Psychedelics May Boost Connectedness with Nature

A new study has looked into how therapeutic psychedelic administration combined with the calm properties of nature-based settings has the capacity to improve an individual’s mental well-being as well as bolster their relationship with nature. The study was conducted by a team of researchers from the Center for Psychedelic Research at Imperial College in London. Its findings were reported in “Health Psychology.” Contact with nature and the therapeutic administration of psychedelics has been linked to similar psychological mechanisms, including amplified states of transcendent experiences and awe, increased psychological connectedness and reduced rumination, which are all processes associated with improvements in…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Month: April 2022

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leveraging Growth Across Multiple Markets Including Mental Health, Healthcare IT

Activists in Michigan Start Signature Collection Efforts for Psychedelic Legalization Ballot Measure

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO to Present at Three Upcoming Investor Conferences Spotlighting the Company’s Strategic Outlook for the Remainder of 2022

Psychedelics May Boost Connectedness with Nature

PsychedelicNewsWire Currently Accepts

PsychedelicNewsWire

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leveraging Growth Across Multiple Markets Including Mental Health, Healthcare IT

Activists in Michigan Start Signature Collection Efforts for Psychedelic Legalization Ballot Measure

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO to Present at Three Upcoming Investor Conferences Spotlighting the Company’s Strategic Outlook for the Remainder of 2022

Psychedelics May Boost Connectedness with Nature

PsychedelicNewsWire Currently Accepts

PsychedelicNewsWire

Company Search

Site Search